|
Type of Company:
Type:
|
Industry Supplier
|
Ownership: |
Government Department or Agency |
Company Size: |
100-499 Employees In BC (100-499 Total)
100-499 In BC (100-499 Total)
|
Year Founded: |
1968 |
Supplier Category: |
Non-Profit Organizations (Science & Tech) |
Region: |
Lower Mainland / South Coast
Lower Mainland
|
Tags: |
TRIUMF, particle accelerator centre
|
|
|
TRIUMF is Canada’s particle accelerator centre. From the hunt for the smallest particles in the universe to the development of new technologies, including next-generation batteries and medical isotopes, TRIUMF is pushing the frontiers in research to advance science, medicine, and business. Established in 1968 in Vancouver, TRIUMF is Canada’s particle accelerator centre. The lab is a hub for discovery and innovation inspired by a half-century of ingenuity in answering nature's most challenging questions. From the hunt for the smallest particles in our universe to research that advances the next generation of batteries or develops isotopes to diagnose and treat disease, TRIUMF drives more than scientific discovery.
Powered by its complement of top talent and advanced accelerator infrastructure, TRIUMF is pushing the frontiers in isotope science and innovation, as well as technologies to address fundamental and applied problems in particle and nuclear physics, and the materials and life sciences.
In collaboration with 20 Canadian universities, TRIUMF's diverse community of nearly 600 multidisciplinary researchers, engineers, technicians, tradespeople, staff, and students create a unique incubator for Canadian excellence, as well as a portal to premier global collaborations.
Our passion for understanding everything from the nature of the nucleus to the creation of the cosmos sparks imagination, inspiration, improved health, economic opportunity, and a better world for all.
From its diversity, cutting-edge research, and world-class facilities, to its competitive benefits package and stunning location, TRIUMF is a great place to work.
|
|
|
Date |
Type |
Amount |
Investors |
Date |
Type |
Amount |
Investors |
|
|
|
|
Jun 17, 2022 |
Target Station Mechanical Technician |
Details
|
Apr 29, 2022 |
Mechanical Engineer Technician |
Details
|
1 - 2 of 2 results
|
|
 |
|
|
|
|
Mar 16, 2021
|
Dr. Nigel Smith appointed as next Director of TRIUMF
|
Dec 18, 2020
|
TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a Cancer-Fighting Medical Isotope
|
Oct 25, 2019
|
TRIUMF and CNL Successfully Produce Rare Medical Isotope That Could Revolutionize Fight Against Cancer (rarest drug on Earth)
|
Apr 4, 2019
|
CDRD and TRIUMF Announce Collaboration to Revolutionize the Fight Against Cancer
|
Mar 22, 2019
|
Vancouver-Based TRIUMF Receives Historic $292.7 Million Funding Commitment in 2019 Federal Budget
|
Nov 6, 2018
|
Prime Minister of Canada Announces Establishment of Centre for Advanced Medical Isotope Research and Development at TRIUMF
|
Jun 26, 2018
|
TRIUMF NEWS: Canada to Lead 'Coldbox' Technology for High-Luminosity LHC Upgrade With $10M From Government of Canada
|
Jan 12, 2018
|
TRIUMF Announces ALPHA Collaboration Shines Light on Antimatter Question
|
Oct 17, 2016
|
BC Government Makes $8.7 Million Investment to Bolster Canada's Rare-Isotope Capabilities
|
Sep 23, 2016
|
ARTMS™ Products Inc. Licenses Canadian Technology to Address the Global Medical Isotope Supply Challenge
|
|
1 - 10 of 14 results
|
|
 |
|
|
|
Share This Company Profile |
|
Disclaimer: Company Profiles in the Tech Directory on T-Net are created, edited and maintained primarily by employees within individual companies, and are subject to continual change without notice and possible errors and/or omissions. Information within the pages of this Tech Directory is of a general nature intended only for informational purposes, and such information should not be relied upon. T-Net does not warrant or guarantee the quality, accuracy or completeness of such information and expressly disclaims liability for any loss, inconvenience or damages (including special, indirect or consequential damages) caused as a result of any errors in, or omissions from, such information. If you see an error, please let us know. Copyright T-Net. All rights reserved.
|
|